Clinicopathological parameters | MYD88 L265P gene mutation | P value | |
Wild type (N = 32) | Mutant type (N = 8) | ||
Ann Arbor staging |
|
| 0.042 |
I-II | 12 | 1 |
|
III-IV | 20 | 7 | |
B symptoms |
|
| 1.000 |
yes | 11 | 3 |
|
no | 21 | 5 | |
ECOG PS score |
|
| 0.202 |
<2 | 23 | 5 |
|
≥2 | 9 | 3 | |
IPI score |
|
| 0.039 |
Low risk | 5 | 0 |
|
Medium-low risk | 13 | 0 | |
Medium-high risk | 11 | 4 | |
Extremely high risk | 3 | 4 | |
NCCN-IPI score |
|
| 0.041 |
Low risk | 6 | 0 |
|
Medium-low | 13 | 2 | |
Medium-high | 10 | 4 | |
Extremely high risk | 3 | 2 |